Raphael Pharmaceutical Inc.
Company Information
Industry Medicinal Chemicals & Botanical Products
SIC Code 2833
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NV
Business Address SUITE 105 - 5348 VEGAS DR., LAS VEGAS, NV, 89108
Mailing Address SUITE 105 - 5348 VEGAS DR., LAS VEGAS, NV, 89108
Phone 702-442-1166
Fiscal Year End 1231
EIN 260204284
Financial Overview
FY2025
-$1.28M
Net Income
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 24, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| 3 Initial insider ownership report | September 8, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 13, 2025 | View on SEC |
| 8-K Current report of material events | August 11, 2025 | View on SEC |
| 8-K Current report of material events | August 11, 2025 | View on SEC |
| 10-Q Quarterly financial report | May 15, 2025 | View on SEC |
Annual Reports
10-K March 31, 2026
- Positive Phase 1/2a clinical trial results for lead arthritis treatment with 72% symptom management.
- Successful launch of 'RaphaWell' supplement, generating $150,000 in initial six-month revenue.
Related Companies
Companies in the same industry (SIC: 2833)
Jushi Holdings Inc.
JUSHF Medicinal Chemicals & Botanical Products
Target Group Inc.
CBDY Medicinal Chemicals & Botanical Products
FITLIFE BRANDS, INC.
FTLF Medicinal Chemicals & Botanical Products
Adia Nutrition, Inc.
ADIA Medicinal Chemicals & Botanical Products
IM Cannabis Corp.
IMCC Medicinal Chemicals & Botanical Products
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.